These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 31243883)

  • 1. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA.
    Lee JS; Park SS; Lee YK; Norton JA; Jeffrey SS
    Mol Oncol; 2019 Aug; 13(8):1623-1650. PubMed ID: 31243883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?
    Liu DSK; Mato Prado M; Giovannetti E; Jiao LR; Krell J; Frampton AE
    Expert Rev Mol Diagn; 2019 Jul; 19(7):553-558. PubMed ID: 31159604
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.
    Riva F; Dronov OI; Khomenko DI; Huguet F; Louvet C; Mariani P; Stern MH; Lantz O; Proudhon C; Pierga JY; Bidard FC
    Mol Oncol; 2016 Mar; 10(3):481-93. PubMed ID: 26856794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.
    Gall TMH; Belete S; Khanderia E; Frampton AE; Jiao LR
    Am J Pathol; 2019 Jan; 189(1):71-81. PubMed ID: 30558725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SST gene hypermethylation acts as a pan-cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood-based diagnosis.
    Manoochehri M; Wu Y; Giese NA; Strobel O; Kutschmann S; Haller F; Hoheisel JD; Moskalev EA; Hackert T; Bauer AS
    Mol Oncol; 2020 Jun; 14(6):1252-1267. PubMed ID: 32243066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Application of Liquid Biopsy in Pancreatic Cancer: A Narrative Review.
    Ramírez-Maldonado E; López Gordo S; Major Branco RP; Pavel MC; Estalella L; Llàcer-Millán E; Guerrero MA; López-Gordo E; Memba R; Jorba R
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant
    Perets R; Greenberg O; Shentzer T; Semenisty V; Epelbaum R; Bick T; Sarji S; Ben-Izhak O; Sabo E; Hershkovitz D
    Oncologist; 2018 May; 23(5):566-572. PubMed ID: 29371474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates of blood-derived circulating tumor DNA in pancreatic cancer.
    Patel H; Okamura R; Fanta P; Patel C; Lanman RB; Raymond VM; Kato S; Kurzrock R
    J Hematol Oncol; 2019 Dec; 12(1):130. PubMed ID: 31801585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsies in pancreatic cancer.
    Kamyabi N; Bernard V; Maitra A
    Expert Rev Anticancer Ther; 2019 Oct; 19(10):869-878. PubMed ID: 31533487
    [No Abstract]   [Full Text] [Related]  

  • 10. Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.
    Bardol T; Dujon AM; Taly V; Dunyach-Remy C; Lavigne JP; Costa-Silva B; Kurma K; Eslami-S Z; Cayrefourcq L; Canivet C; Muscari F; Bournet B; Alix-Panabières C
    BMC Cancer; 2024 Jun; 24(1):709. PubMed ID: 38853244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfaceome profiling enables isolation of cancer-specific exosomal cargo in liquid biopsies from pancreatic cancer patients.
    Castillo J; Bernard V; San Lucas FA; Allenson K; Capello M; Kim DU; Gascoyne P; Mulu FC; Stephens BM; Huang J; Wang H; Momin AA; Jacamo RO; Katz M; Wolff R; Javle M; Varadhachary G; Wistuba II; Hanash S; Maitra A; Alvarez H
    Ann Oncol; 2018 Jan; 29(1):223-229. PubMed ID: 29045505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Assessment of Response Status in Patients with Pancreatic Cancer Treated with Neoadjuvant Therapy using Somatic Mutations and Liquid Biopsy Analysis.
    Yin L; Pu N; Thompson E; Miao Y; Wolfgang C; Yu J
    Clin Cancer Res; 2021 Feb; 27(3):740-748. PubMed ID: 33082211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma circulating tumor DNA in pancreatic adenocarcinoma for screening, diagnosis, prognosis, treatment and follow-up: A systematic review.
    Abdallah R; Taly V; Zhao S; Pietrasz D; Bachet JB; Basile D; Mas L; Zaanan A; Laurent-Puig P; Taieb J
    Cancer Treat Rev; 2020 Jul; 87():102028. PubMed ID: 32485509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.
    Cohen JD; Javed AA; Thoburn C; Wong F; Tie J; Gibbs P; Schmidt CM; Yip-Schneider MT; Allen PJ; Schattner M; Brand RE; Singhi AD; Petersen GM; Hong SM; Kim SC; Falconi M; Doglioni C; Weiss MJ; Ahuja N; He J; Makary MA; Maitra A; Hanash SM; Dal Molin M; Wang Y; Li L; Ptak J; Dobbyn L; Schaefer J; Silliman N; Popoli M; Goggins MG; Hruban RH; Wolfgang CL; Klein AP; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Lennon AM
    Proc Natl Acad Sci U S A; 2017 Sep; 114(38):10202-10207. PubMed ID: 28874546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer.
    Rofi E; Vivaldi C; Del Re M; Arrigoni E; Crucitta S; Funel N; Fogli S; Vasile E; Musettini G; Fornaro L; Falcone A; Danesi R
    Pharmacogenomics; 2019 Jan; 20(1):49-68. PubMed ID: 30520336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in Liquid Biopsy Technology and Implications for Pancreatic Cancer.
    Raufi AG; May MS; Hadfield MJ; Seyhan AA; El-Deiry WS
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Significance of Circulating Tumor Cells in Pancreatic Cancer.
    Habib JR; Javed AA; Wolfgang CL
    Adv Surg; 2024 Sep; 58(1):135-142. PubMed ID: 39089773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building on the clinical applicability of ctDNA analysis in non-metastatic pancreatic ductal adenocarcinoma.
    Labiano I; Huerta AE; Alsina M; Arasanz H; Castro N; Mendaza S; Lecumberri A; Gonzalez-Borja I; Guerrero-Setas D; Patiño-Garcia A; Alkorta-Aranburu G; Hernández-Garcia I; Arrazubi V; Mata E; Gomez D; Viudez A; Vera R
    Sci Rep; 2024 Jul; 14(1):16203. PubMed ID: 39003322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reviews on Current Liquid Biopsy for Detection and Management of Pancreatic Cancers.
    Kaczor-Urbanowicz KE; Cheng J; King JC; Sedarat A; Pandol SJ; Farrell JJ; Wong DTW; Kim Y
    Pancreas; 2020 Oct; 49(9):1141-1152. PubMed ID: 33003085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.